Medical/Pharmaceuticals News & Press Release Distribution

Antengene Announces XPOVIO® Regulatory Approval in Taiwan for the Treatment of Relapsed and/or Refractory Multiple Myeloma and Diffuse Large B-Cell Lymphoma

- XPOVIO® is the first and only exportin 1 (XPO1) inhibitor approved in Taiwan - Antengene plans to submit for national health insurance reimbursement inTaiwan for XPOVIO® in Q4 2022 SHANGHAI and HONG KONG, Oct. 21, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEH...

2022-10-21 20:37 6235

SIRONA completes enrollment - A leap in the DCB treatment of femoropopliteal arterial disease

TAMPA, Fla., Oct. 21, 2022 /PRNewswire/ -- Concept Medical Inc. announces the successful completion of the SIRONA - World's first and the largest head-to-head RCT investigating the use of Sirolimus Drug Coated Balloon (DCB) (Magic Touch PTA

2022-10-21 20:36 4744

SIRONA completes enrollment - A leap in the DCB treatment of femoropopliteal arterial disease

SK bioscience Appoints New Executives towards Global Business Growth

* Global experts continue to join SK bioscience, while its U.S. corporate entity is being established * Company plans to strategically invest in personnel, innovation & infrastructure to ensure global competitiveness SEOUL, South Korea, Oct. 21, 2022 /PRNewswire/ -- SK bioscience, a global in...

2022-10-21 20:00 3822

SK bioscience Appoints New Executives towards Global Business Growth

AFTER 30 YEARS -- NEW GUIDELINES FOR WEIGHT-LOSS SURGERY

Medical Groups Replace Outdated Consensus Statement that Overly Restricts Access to Modern-Day Weight-Loss Surgery NEWBERRY, Fla., Oct. 21, 2022 /PRNewswire/ -- Two of the world's leading authorities on bariatric and metabolic surgery have issued new evidence-based clinical guidelines that among...

2022-10-21 18:30 5529

MGI Contributes to Thailand's Roadmap for Genomic Medicine in Genomics Thailand Initiative

BANGKOK, Oct, 21 2022 /PRNewswire/ -- MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, today announced the supply of its products* to support the sequencing of the genomes of 50,000 Thai individuals as part of the Genomics Thailand Initiativ...

2022-10-21 11:00 4439

Akeso's Ivonescimab (PD-1/VEGF BsAbs) Granted Breakthrough Therapy Designation by China NMPA for the Treatment of Advanced NSCLC

HONG KONG, Oct. 20, 2022 /PRNewswire/ -- Akeso, Inc. (9926. HK) ("Akeso"), a China-based biopharmaceutical company focusing on the development and commercialization of innovative therapeutic antibodies for Oncology & Immunology, announced that the Center for Drug Evaluation (CDE) of China Nation...

2022-10-21 09:15 2867

132nd Canton Fair Gives Full Play to the Advantages of China's Medical and Health Industry to Provide Quality Health Care Choices

GUANGZHOU, China, Oct. 20, 2022 /PRNewswire/ -- The 132nd Canton Fair, which started onOctober 15th, 2022, gathers leading companies from China's health industr -- giving full play to its industry advantages and while providing global consumers with better health care choices. Among them, Crown ...

2022-10-20 20:49 2226

132nd Canton Fair Gives Full Play to the Advantages of China's Medical and Health Industry to Provide Quality Health Care Choices

AUM Biosciences and Asymchem Complete Phase II API Production Campaign of Novel TRK Inhibitor

TEDA TIANJIN, P.R. China and SINGAPORE, Oct. 20, 2022 /PRNewswire/ -- Asymchem (stock code: 002821.SZ), a leading global contract development and manufacturing service provider, and AUM Biosciences (AUM), a global clinical stage biotech company, focused on discovering, acquiring and developing ne...

2022-10-20 20:30 3004

Grand Opening of 'Medlab Asia & Asia Health 2022' in Thailand

BANGKOK, Oct. 20, 2022 /PRNewswire/ -- Thailand's Minister of Public Health officiates Medlab Asia & Asia Health 2022, the leading trade exhibition within the medical laboratory industry in the ASEAN region, organised by Informa Markets and IMPACT Exhibition Management, attracting over 11,000 par...

2022-10-20 16:48 2983

Grand Opening of 'Medlab Asia & Asia Health 2022' in Thailand

Harbour BioMed Announces Dosing of First Patient in Phase I Trial of B7H4x4-1BB Bispecific Antibody in the United States

CAMBRIDGE, Mass., ROTTERDAM and SUZHOU, China, Oct. 20, 2022 /PRNewswire/ -- Harbour BioMed ("HBM", HKEX: 02142) announced that, it has successfully completed the dosing of first patient in the global phase I trial of B7H4x4-1BB bispecific antibody HBM7008 inthe United States. This study will eva...

2022-10-20 16:20 2599

BGI Australia Receives NATA Certification for Clinical Whole Exome Sequencing

BRISBANE, Australia, Oct. 20, 2022 /PRNewswire/ -- BGI Australia's lab has achieved accreditation from the National Association of Testing Authorities (NATA) to perform clinical Whole Exome Sequencing inAustralia, paving the way for the global life sciences company to provide clinical sequencing ...

2022-10-20 15:31 2399

BGI Australia Receives NATA Certification for Clinical Whole Exome Sequencing

BRISBANE, Australia, Oct. 20, 2022 /PRNewswire/ -- BGI Australia's lab has achieved accreditation from the National Association of Testing Authorities (NATA) to perform clinical Whole Exome Sequencing inAustralia, paving the way for the global life sciences company to provide clinical sequencing ...

2022-10-20 15:27 2255

ALFASIGMA ACQUIRES SOFAR'S ENTIRE SHARE CAPITAL, AN ITALIAN PHARMACEUTICAL COMPANY

POMEZIA, Italy, Oct. 20, 2022 /PRNewswire/ -- Alfasigma S.p.A. has completed the acquisition of SOFAR S.p.A., thus officially beginning the integrating process of the two companies. The transaction, which was launched last August and was scheduled for completion inOctober 2022, was success...

2022-10-20 14:45 2192

Millions of Women who Suffer from Pelvic Pain Still Unaware of Pelvic Venous Congestion Syndrome PVCS

SYDNEY, Oct. 20, 2022 /PRNewswire/ -- Pelvic pain is a common condition affecting millions of women around the world, with up to 40% affected during their lifetime. Of those affected, 30% suffer from Pelvic Venous Congestion Syndrome (PVCS). Boston Scientific haslaunched a new website

2022-10-20 10:00 2645

AASLD 2022 | Ascentage Pharma to Announce Results from First-in-Human Study of IAP Antagonist APG-1387 in an Oral Report at the AASLD Annual Meeting

SUZHOU, China and ROCKVILLE, Md., Oct. 19, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that it will release results from the Phase I fir...

2022-10-20 07:16 2332

Telix Reports Third Quarter 2022 Financial Results

MELBOURNE, Australia, Oct. 20, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly cash flow statement and accompanying Activities Report for the quarter ended30 September 2022 (Q3 2022). All figures are in AUD$ unless otherwise...

2022-10-20 06:09 2656

On World Osteoporosis Day, take five steps to better bone health

NYON, Switzerland, Oct. 20, 2022 /PRNewswire/ -- Today, on World Osteoporosis Day, the International Osteoporosis Foundation (IOF) calls on people of all ages to be proactive in taking steps for better bone health and osteoporosis prevention. Osteoporosis is a bone disease that affects some 500...

2022-10-20 06:00 2689

Biostarks Designated As Official Biomarker Testing Kit of the Global Ironman Triathlon Series and Title Partner of the 2022 Ironman Arizona Triathlon, Part of the Vinfast Ironman U.S. Series

SOUTH JORDAN, Utah, Oct. 19, 2022 /PRNewswire/ -- Biostarks, a preventative health and wellness company, recently announced a multi-year partnership as the Official Biomarker Testing Kit of the Global IRONMAN® Triathlon Series. The partnership kicked offOct. 6 & 8, 2022 at the 2022 VinFast IRONMA...

2022-10-19 21:00 2090

NCCN Guidelines for Patients Win Award for Excellence in Cancer Patient Education from CPEN

National Comprehensive Cancer Network's breast cancer patient resources honored for unique support of diversity, equity, and inclusion, available free at NCCN.org/patientresources. PLYMOUTH MEETING, Pa., Oct. 19, 2022 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance ...

2022-10-19 20:37 1908

NCCN Guidelines for Patients Win Award for Excellence in Cancer Patient Education from CPEN

SeekIn Presents New Data Supporting its Pan-cancer Early Detection Test at the Early Detection of Cancer Conference 2022

The large case-control study demonstrates that SeekInCare® has 68.0% sensitivity at 98.0% specificity in 27 different cancer types as a whole. In both retrospective and prospective studies, the solid performance of SeekInCare® puts it into best-in-class category of multi-cancer early detection (...

2022-10-19 20:30 1819